Test Price
1,800 AED✅ Home Collection Available
Maternal Myopathy with Cardiomyopathy (MMC) Mutation Detection Test in UAE | 1800 AED | DNA Labs UAE
Executive Summary & Core Metrics
Accuracy Guarantee:
99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics:
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance:
Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed specialists.
Insurance:
Direct Billing Verification via WhatsApp
+971 54 548 8731
Test Overview & Methodology
The MMC Mutation Detection Test identifies pathogenic variants in nuclear and mitochondrial genes responsible for maternal myopathy with cardiomyopathy, enabling precise diagnosis, carrier screening, and personalised cardiac surveillance. This test employs Next-Generation Sequencing (NGS) with targeted PCR confirmation to detect mutations associated with maternally inherited muscle and heart disorders.
| Feature | Our Test (NGS+PCCR) | Closest Alternative (PCR Only Panel) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) + Targeted PCR Confirmation | Conventional PCR / Sanger sequencing of limited genes |
| Diagnostic Yield | >95% for clinically actionable variants | 60–75% (depends on panel size) |
| Turnaround Time | 10 days | 14–21 days |
| Regulatory Compliance | ISO 9001:2015, DHA Licensed (Facility: 1143), UAE PDPL | Variable |
| Sample Type | 4 mL EDTA whole blood, refrigerated (never freeze) | Similar |
| Price | 1800 AED | ~2200–2500 AED |
Physician Insight & Safety Protocols
"The clinical spectrum of maternal myopathy with cardiomyopathy requires a high index of suspicion, as presenting symptoms can be subtle. This molecular test provides definitive evidence of pathogenic variants; however, results should be correlated with electrocardiographic and echocardiographic findings. Family cascade screening is strongly recommended when a pathogenic variant is identified."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Medication Advisory
Medication Warning: Do not discontinue any prescribed medication (e.g., beta‑blockers, ACE inhibitors) without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Samples that have been frozen, haemolysed, or collected in incorrect tube type.
- Exclusion: Missing or incomplete Genomics Clinical Information Requisition Form (Form 20) – test will not proceed.
- Emergency Red Flag: If you develop sudden severe muscle weakness, chest pain, palpitations, or shortness of breath, visit the nearest Emergency Department immediately.
- Emergency Red Flag: Rapid progression of limb‑girdle weakness or signs of cardiac decompensation require urgent cardiology evaluation.
Patient FAQ & Clinical Guidance
1. What exactly does the MMC Mutation Detection Test look for?
This test analyses the complete coding regions of nuclear and mitochondrial genes associated with maternal myopathy with cardiomyopathy using next‑generation sequencing to detect disease‑causing variants. Results can confirm a clinical diagnosis and guide cardiac surveillance planning.
2. How should I prepare for the blood draw, and why is Form 20 mandatory?
No fasting is required, but you must complete the Genomics Clinical Information Requisition Form (Form 20) in full because it ensures accurate clinical correlation and regulatory compliance for genetic testing procedures.
3. What does a positive result mean for my family?
A positive result indicates a maternally inherited variant, meaning siblings and maternal relatives may also be at risk and should consider genetic counselling and cascade testing to assess their own cardiac and muscle health.
UAE Regulatory & Data Privacy Adherence
This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE is licensed by the Dubai Health Authority (DHA) under Facility License Number 1143 and operates in full compliance with UAE healthcare regulations.
Clinical & Logistical Metadata
| Test Name | Maternal Myopathy with Cardiomyopathy (MMC) Mutation Detection |
| Price (AED) | 1,800 AED |
| Turnaround Time | 10 business days |
| Sample Type / Matrix | 4 mL EDTA whole blood (refrigerated, never frozen) |
| Methodology Used | Next-Generation Sequencing (NGS) + Targeted PCR Confirmation |
| ICD-10-CM Code | G71.0, I42.9 |
| LOINC Code | 81247-9 |
| DHA Facility License & Laboratory Address | DHA Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians